Glenn R. Mattes Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Glenn R. Mattes.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Glenn R. Mattes. Glenn R. Mattes is President & CEO in Arno Therapeutics, Inc ($ARNI) and President and CEO in TFF Pharmaceuticals, Inc. ($TFFP).

Latest Insider Trading Transactions of Glenn R. Mattes

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARNI, TFFP

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 17 2021TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOOption ExerciseM2.5050,000125,000944,227
Mar 17 2021TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOSellS17.0450,000852,00010,00060 K to 10 K (-83.33 %)
Mar 17 2021TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOBuyM2.5050,000125,00060,00010 K to 60 K (+500.00 %)
Feb 18 2021TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOOption ExerciseM2.5040,000100,000994,227
Feb 18 2021TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOSellS16.8240,000672,80010,00050 K to 10 K (-80.00 %)
Feb 18 2021TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOBuyM2.5040,000100,00050,00010 K to 50 K (+400.00 %)
Jan 20 2021TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOOption ExerciseM2.5040,000100,0001,034,227
Jan 20 2021TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOSellS17.5140,000700,40010,00050 K to 10 K (-80.00 %)
Jan 20 2021TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOBuyM2.5040,000100,00050,00010 K to 50 K (+400.00 %)
Jan 20 2021TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOSellS17.003,00051,0007,00010 K to 7 K (-30.00 %)
Dec 29 2020TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOOption ExerciseM2.5030,00075,0001,074,227
Dec 29 2020TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOSellS15.3330,000459,90010,00040 K to 10 K (-75.00 %)
Dec 29 2020TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOBuyM2.5030,00075,00040,00010 K to 40 K (+300.00 %)
Nov 13 2020TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOOption ExerciseM2.50108,830272,0751,104,227
Nov 13 2020TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOSellS15.00108,8301,631,90610,000118.8 K to 10 K (-91.58 %)
Nov 13 2020TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOBuyM2.50108,830272,075118,83010 K to 118.8 K (+1,088.30 %)
Aug 26 2020TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOOption ExerciseA13.65152,0002,074,8001,213,057
Aug 26 2020TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOOption ExerciseA5.0089,952449,7601,061,057
Dec 03 2019TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOOption ExerciseA5.0025,214126,070971,105
Oct 29 2019TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOOption ExerciseA5.00332,8681,664,340945,891
Oct 29 2019TFFPTFF Pharmaceutical ...Mattes Glenn R.President and CEOBuyP5.0010,00050,00010,0000 to 10 K
Jan 28 2014ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOOption ExerciseA2.90408,8921,185,787408,892
Nov 06 2013ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOOption ExerciseA2.40386,697928,073386,697
Oct 31 2013ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOOption ExerciseP2.4020,83349,99920,833
Oct 31 2013ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOOption ExerciseP4.0020,83383,33220,833
Oct 31 2013ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOOption ExerciseA2.4020,83349,99920,833
Oct 31 2013ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOOption ExerciseD2.4020,83349,9990
Oct 31 2013ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOOption ExerciseC2.4020,83349,9990
Oct 31 2013ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOBuyP0.0020,833077,20356.4 K to 77.2 K (+36.96 %)
Oct 31 2013ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOGrantA2.401,6663,99856,37054.7 K to 56.4 K (+3.05 %)
Oct 31 2013ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOBuyC2.4022,21853,32354,70432.5 K to 54.7 K (+68.39 %)
May 30 2013ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOBuyJ0.303,222967259,888256.7 K to 259.9 K (+1.26 %)
May 07 2013ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOBuyJ0.303,3331,000256,666253.3 K to 256.7 K (+1.32 %)
Apr 09 2013ARNIArno Therapeutics, ...Mattes Glenn R.President & CEOBuyJ0.303,3331,000253,333250 K to 253.3 K (+1.33 %)

Page:   1